Formulation: A crystalline solid
Formal Name: 4-hydroxy-α-[1-[(1-methyl-3-phenylpropyl)amino]ethyl]-benzenemethanol
Purity: ≥85%
Formula Markup: C19H25NO2
Formula Weight: 299,4
Shelf life (days): 1460
CAS Number: 447-41-6
Notes: Nylidrin is an agonist of β-adrenergic receptors and antagonist of NR1A/2B subunit-containing NMDA receptors.{54827,54828} It binds to β-adrenergic receptors (Kd = 0.37 µM) and activates adenylate cyclase with a Ka value of 1.3 µM.{54827} Nylidrin is selective for NR1A/2B over NR1A/2A and NR1A/2C subunit-containing NMDA receptors (IC50s = 0.18, 32, and 42 µM, respectively, for the recombinant receptors expressed in Xenopus oocytes).{54828} It inhibits NMDA-induced currents in primary rat cortical neurons (IC50 = 0.22 µM). It also decreases blood pressure and increases heart rate in spontaneously hypertensive rats (SHRs) with a minimum effective dose (MED) of 0.5 mg/kg.{54829} Nylidrin (20 and 100 µM) inhibits influenza hemagglutinin 2-mediated membrane fusion in Vero E6 cells.{57347} It inhibits infection of MDCK cells by H1N1 and H3N2 influenza isolates in vitro (EC50s = 7.2 and 12.1 µM, respectively) and prevents infection in a mouse model of mouse-adapted H1N1 infection.
English
Deutsch
